Shares of Third Wave Technologies rose 8.4 percent for the five-day trading period ended Tuesday. The firm’s stock is up 17.7 percent since announcing on Dec. 5 that it had received the CE Mark for its HPV molecular diagnostic test, allowing it to sell the test throughout the European Union.
Qiagen led decliners for the week with a drop of 5.9 percent. Overall, 16 of the 21 stocks in the BCW Index lost value during the tracking period, and the Index closed down 1.1 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.